Cost consequences of HIV-associated lipoatrophy

By Hornberger J.   Rajagopalan R.   Shewade A.   Loutfy M. R.  

AIDS Care, Vol. 21, Iss. 5, 2009-05 ,pp. : 664-671

Routledge Ltd

Access to resources Recommend Favorite

Impact of lipoatrophy on quality of life in HIV patients receiving anti-retroviral therapy

By Rajagopalan Rukmini   Laitinen David   Dietz Birgitta  

AIDS Care, Vol. 20, Iss. 10, 2008-11 ,pp. : 1197-1201

Routledge Ltd

Access to resources Recommend Favorite

Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy

By Antoniou Tony   Raboud Janet   Kovacs Colin   Diong Christina   Brunetta Jason   Smith Graham   Halpenny Roberta   Beninger Francis   Loutfy Mona  

AIDS Care, Vol. 21, Iss. 10, 2009-10 ,pp. : 1247-1252

Routledge Ltd

Access to resources Recommend Favorite

An Economic Evaluation of Treatments for HIV-Associated Facial Lipoatrophy: A Cost-Utility Analysis

By  

Current HIV Research, Vol. 8, Iss. 5, 2010-07 ,pp. : 386-395

Bentham Science Publishers

Access to resources Recommend Favorite

Accuracy of Ultrasound Imaging Technique for Assessing Lipoatrophy in HIV-Infected Subjects

By  

Current HIV Research, Vol. 9, Iss. 5, 2011-07 ,pp. : 327-333

Bentham Science Publishers

Access to resources Recommend Favorite